Clinical Trial

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 23, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of single ascending doses of AZD0292 administered via intravenous (IV) infusion in healthy Japanese participants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-10-28; most recent amendment 2026-06-19.
Status change: Recruiting → Active, Not Recruiting 2026-03-04
Status change: Not Yet Recruiting → Recruiting 2025-12-17
Trial Details
NCT Number NCT07222254
Lead Sponsor AstraZeneca
Conditions Healthy Participants
Enrollment 18 participants
Start Date 2025-12-12
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-23